|
1
|
Global Burden of Disease Cancer
Collaboration, . Fitzmaurice C, Allen C, Barber RM, Barregard L,
Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al:
Global, regional, and National cancer incidence, mortality, years
of life lost, years lived with disability, and disability-adjusted
life-years for 32 cancer groups, 1990 to 2015: A systematic
analysis for the global burden of disease study. JAMA Oncol.
3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
|
3
|
Zheng R, Zeng H, Zhang S and Chen W:
Estimates of cancer incidence and mortality in China, 2013. Chin J
Cancer. 36:662017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou L, Lv T, Zhang Q, Zhu Q, Zhan P, Zhu
S, Zhang J and Song Y: The biology, function and clinical
implications of exosomes in lung cancer. Cancer Lett. 407:84–92.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi H, Liu C, Long L, Ren Y, Zhang S, Chang
X, Qian X, Jia H, Zhao J, Sun J, et al: Blood exosomes endowed with
magnetic and targeting properties for cancer therapy. ACS Nano.
10:3323–3333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greening DW, Gopal SK, Xu R, Simpson RJ
and Chen W: Exosomes and their roles in immune regulation and
cancer. Semin Cell Dev Biol. 40:72–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taylor DD and Gercel-Taylor C:
Exosomes/microvesicles: Mediators of cancer-associated
immunosuppressive microenvironments. Semin Immunopathol.
33:441–454. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao L, Liu W, Xiao J and Cao B: The role
of exosomes and ‘exosomal shuttle microRNA’ in tumorigenesis and
drug resistance. Cancer Lett. 356:339–346. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frydrychowicz M, Kolecka-Bednarczyk A,
Madejczyk M, Yasar S and Dworacki G: Exosomes-structure, biogenesis
and biological role in non-small-cell lung cancer. Scand J Immunol.
81:2–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aqil F, Munagala R, Jeyabalan J, Agrawal
AK and Gupta R: Exosomes for the enhanced tissue bioavailability
and efficacy of curcumin. AAPS J. 19:1691–1702. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercellular communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schneider A and Simons M: Exosomes:
Vesicular carriers for intercellular communication in
neurodegenerative disorders. Cell Tissue Res. 352:33–47. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mathivanan S, Ji H and Simpson RJ:
Exosomes: Extracellular organelles important in intercellular
communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Villarroya-Beltri C, Baixauli F,
Gutiérrez-Vázquez C, Sánchez-Madrid F and Mittelbrunn M: Sorting it
out: Regulation of exosome loading. Semin Cancer Biol. 28:3–13.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hannafon BN and Ding WQ: Intercellular
communication by exosome-derived microRNAs in cancer. Int J Mol
Sci. 14:14240–14269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Keerthikumar S, Chisanga D, Ariyaratne D,
Al Saffar H, Anand S, Zhao K, Samuel M, Pathan M, Jois M,
Chilamkurti N, et al: ExoCarta: A web-based compendium of exosomal
cargo. J Mol Biol. 428:688–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ludwig AK and Giebel B: Exosomes: Small
vesicles participating in intercellular communication. Int J
Biochem Cell Biol. 44:11–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iraci N, Leonardi T, Gessler F, Vega B and
Pluchino S: Focus on extracellular vesicles: Physiological role and
signalling properties of extracellular membrane vesicles. Int J Mol
Sci. 17:1712016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Li C, Zhou T, Liu X, Liu X, Li X and
Chen D: Role of exosomal proteins in cancer diagnosis. Mol Cancer.
16:1452017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hannafon BN, Carpenter KJ, Berry WL,
Janknecht R, Dooley WC and Ding WQ: Exosome-mediated microRNA
signaling from breast cancer cells is altered by the
anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer.
14:1332015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kapetanakis NI, Baloche V and Busson P:
Tumor exosomal microRNAs thwarting anti-tumor immune responses in
nasopharyngeal carcinomas. Ann Transl Med. 5:1642017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomou T, Mori MA, Dreyfuss JM, Konishi M,
Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R,
Grinspoon SK, et al: Adipose-derived circulating miRNAs regulate
gene expression in other tissues. Nature. 542:450–455. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ying W, Riopel M, Bandyopadhyay G, Dong Y,
Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A,
Fu W, et al: Adipose tissue macrophage-derived exosomal miRNAs can
modulate in vivo and in vitro insulin sensitivity. Cell.
171:372–384.e12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi R, Zhao L, Cai W, Wei M, Zhou X, Yang
G and Yuan L: Maternal exosomes in diabetes contribute to the
cardiac development deficiency. Biochem Biophys Res Commun.
483:602–608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1568–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pfeffer SR, Grossmann KF, Cassidy PB, Yang
CH, Fan M, Kopelovich L, Leachman SA and Pfeffer LM: Detection of
exosomal miRNAs in the plasma of melanoma patients. J Clin Med.
4:2012–2027. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Watahiki A, Macfarlane RJ, Gleave ME, Crea
F, Wang Y, Helgason CD and Chi KN: Plasma miRNAs as biomarkers to
identify patients with castration-resistant metastatic prostate
cancer. Int J Mol Sci. 14:7757–7770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu R, Greening DW, Rai A, Ji H and Simpson
RJ: Highly-purified exosomes and shed microvesicles isolated from
the human colon cancer cell line LIM1863 by sequential centrifugal
ultrafiltration are biochemically and functionally distinct.
Methods. 87:11–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Subra C, Laulagnier K, Perret B and Record
M: Exosome lipidomics unravels lipid sorting at the level of
multivesicular bodies. Biochimie. 89:205–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Record M, Carayon K, Poirot M and
Silvente-Poirot S: Exosomes as new vesicular lipid transporters
involved in cell-cell communication and various pathophysiologies.
Biochim Biophys Acta. 1841:108–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li P, Kaslan M, Lee SH, Yao J and Gao Z:
Progress in exosome isolation techniques. Theranostics. 7:789–804.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Caradec J, Kharmate G, Hosseini-Beheshti
E, Adomat H, Gleave M and Guns E: Reproducibility and efficiency of
serum-derived exosome extraction methods. Clin Biochem.
47:1286–1292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baranyai T, Herczeg K, Onódi Z, Voszka I,
Módos K, Marton N, Nagy G, Mäger I, Wood MJ, El Andaloussi S, et
al: Isolation of exosomes from blood plasma: Qualitative and
quantitative comparison of ultracentrifugation and size exclusion
chromatography methods. PLoS One. 10:e01456862015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peterson MF, Otoc N, Sethi JK, Gupta A and
Antes TJ: Integrated systems for exosome investigation. Methods.
87:31–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu L and Risch HA: Exosomes: Potential for
early detection in pancreatic cancer. Future Oncol. 12:1081–1090.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeringer E, Barta T, Li M and Vlassov AV:
Strategies for isolation of exosomes. Cold Spring Harb Protoc.
2015:319–323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Taylor DD and Shah S: Methods of isolating
extracellular vesicles impact down-stream analyses of their
cargoes. Methods. 87:3–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ban JJ, Lee M, Im W and Kim M: Low pH
increases the yield of exosome isolation. Biochem Biophys Res
Commun. 461:76–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marczak S, Richards K, Ramshani Z, Smith
E, Senapati S, Hill R, Go DB and Chang HC: Simultaneous isolation
and preconcentration of exosomes by ion concentration polarization.
Electrophoresis. Feb 27–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tauro BJ, Greening DW, Mathias RA, Ji H,
Mathivanan S, Scott AM and Simpson RJ: Comparison of
ultracentrifugation, density gradient separation, and
immunoaffinity capture methods for isolating human colon cancer
cell line LIM1863-derived exosomes. Methods. 56:293–304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vaswani K, Koh YQ, Almughlliq FB, Peiris
HN and Mitchell MD: A method for the isolation and enrichment of
purified bovine milk exosomes. Reprod Biol. 17:341–348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Muller L, Hong CS, Stolz DB, Watkins SC
and Whiteside TL: Isolation of biologically-active exosomes from
human plasma. J Immunol Methods. 411:55–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Witwer KW, Buzás EI, Bemis LT, Bora A,
Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog
J, et al: Standardization of sample collection, isolation and
analysis methods in extracellular vesicle research. J Extracell
Vesicles. 2:2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kadota T, Yoshioka Y, Fujita Y, Kuwano K
and Ochiya T: Extracellular vesicles in lung cancer-From bench to
bedside. Semin Cell Dev Biol. 67:39–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nanavaty P, Alvarez MS and Alberts WM:
Lung cancer screening: Advantages, controversies, and applications.
Cancer Control. 21:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pletnikoff PP, Laukkanen JA, Tuomainen TP,
Kauhanen J, Rauramaa R, Ronkainen K and Kurl S: Cardiorespiratory
fitness, C-reactive protein and lung cancer risk: A prospective
population-based cohort study. Eur J Cancer. 51:1365–1370. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rabinowits G, Gercel-Taylor C, Day JM,
Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker
for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Munagala R, Aqil F and Gupta RC: Exosomal
miRNAs as biomarkers of recurrent lung cancer. Tumour Biol.
37:10703–10714. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z,
Xiang Y, Wu N, Wu L, Bai L and Li Y: Circulating exosomal microRNAs
as prognostic biomarkers for non-small-cell lung cancer.
Oncotarget. 8:13048–13058. 2017.PubMed/NCBI
|
|
54
|
Yamashita T, Kamada H, Kanasaki S, Maeda
Y, Nagano K, Abe Y, Inoue M, Yoshioka Y, Tsutsumi Y, Katayama S, et
al: Epidermal growth factor receptor localized to exosome membranes
as a possible biomarker for lung cancer diagnosis. Pharmazie.
68:969–973. 2013.PubMed/NCBI
|
|
55
|
Sandfeld-Paulsen B, Aggerholm-Pedersen N,
Bæk R, Jakobsen KR, Meldgaard P, Folkersen BH, Rasmussen TR,
Varming K, Jørgensen MM and Sorensen BS: Exosomal proteins as
prognostic biomarkers in non-small cell lung cancer. Mol Oncol.
10:1595–1602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ueda K, Ishikawa N, Tatsuguchi A, Saichi
N, Fujii R and Nakagawa H: Antibody-coupled monolithic silica
microtips for highthroughput molecular profiling of circulating
exosomes. Sci Rep. 4:62322014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ostrowski K and Kinsner A: Inhibition of
angiogenesis in the treatment of tumors. Arch Immunol Ther Exp
(Warsz). 49:27–31. 2001.PubMed/NCBI
|
|
58
|
Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X,
Shi L, Lu X, Xu W, Lu L, et al: STAT3-regulated exosomal miR-21
promotes angiogenesis and is involved in neoplastic processes of
transformed human bronchial epithelial cells. Cancer Lett.
370:125–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hsu YL, Hung JY, Chang WA, Lin YS, Pan YC,
Tsai PH, Wu CY and Kuo PL: Hypoxic lung cancer-secreted exosomal
miR-23a increased angiogenesis and vascular permeability by
targeting prolyl hydroxylase and tight junction protein ZO-1.
Oncogene. 36:4929–4942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fabbri M, Paone A, Calore F, Galli R,
Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al:
MicroRNAs bind to Toll-like receptors to induce prometastatic
inflammatory response. Proc Natl Acad Sci USA. 109:E2110–E2116.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X,
Shen B, Liu S, Yan D and Feng J: Cisplatin-resistant lung cancer
cell-derived exosomes increase cisplatin resistance of recipient
cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine.
12:3721–3733. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yuwen DL, Sheng BB, Liu J, Wenyu W and Shu
YQ: MiR-146a-5p level in serum exosomes predicts therapeutic effect
of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol
Sci. 21:2650–2658. 2017.PubMed/NCBI
|
|
63
|
Lobb RJ, van Amerongen R, Wiegmans A, Ham
S, Larsen JE and Möller A: Exosomes derived from mesenchymal
non-small cell lung cancer cells promote chemoresistance. Int J
Cancer. 141:614–620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang FS, Fan JG, Zhang Z, Gao B and Wang
HY: The global burden of liver disease: The major impact of China.
Hepatology. 60:2099–2108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li X and Xu WF: China's efforts to shed
its title of ‘Leader in liver disease’. Drug Discov Ther. 1:84–85.
2007.PubMed/NCBI
|
|
66
|
Wong MC, Jiang JY, Goggins WB, Liang M,
Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW and Chan HL:
International incidence and mortality trends of liver cancer: A
global profile. Sci Rep. 7:458462017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY,
Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel
biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang H, Hou L, Li A, Duan Y, Gao H and
Song X: Expression of serum exosomal microRNA-21 in human
hepatocellular carcinoma. Biomed Res Int.
2014:8648942014.PubMed/NCBI
|
|
69
|
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao
B, Dai Z, Cao Y, Fan J and Zhou J: Serum exosomal miR-125b is a
novel prognostic marker for hepatocellular carcinoma. Onco Targets
Ther. 10:3843–3851. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kogure T, Lin WL, Yan IK, Braconi C and
Patel T: Intercellular nanovesicle-mediated microRNA transfer: A
mechanism of environmental modulation of hepatocellular cancer cell
growth. Hepatology. 54:1237–1248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wei JX, Lv LH, Wan YL, Cao Y, Li GL, Lin
HM, Zhou R, Shang CZ, Cao J, He H, et al: Vps4A functions as a
tumor suppressor by regulating the secretion and uptake of exosomal
microRNAs in human hepatoma cells. Hepatology. 61:1284–1294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Mishra SK, Siddique HR and Saleem M:
S100A4 calcium-binding protein is key player in tumor progression
and metastasis: Preclinical and clinical evidence. Cancer
Metastasis Rev. 31:163–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tse EY, Ko FC, Tung EK, Chan LK, Lee TK,
Ngan ES, Man K, Wong AS, Ng IO and Yam JW: Caveolin-1
overexpression is associated with hepatocellular carcinoma
tumourigenesis and metastasis. J Pathol. 226:645–653. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Cokakli M, Erdal E, Nart D, Yilmaz F,
Sagol O, Kilic M, Karademir S and Atabey N: Differential expression
of Caveolin-1 in hepatocellular carcinoma: Correlation with
differentiation state, motility and invasion. BMC Cancer. 9:652009.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
He M, Qin H, Poon TC, Sze SC, Ding X, Co
NN, Ngai SM, Chan TF and Wong N: Hepatocellular carcinoma-derived
exosomes promote motility of immortalized hepatocyte through
transfer of oncogenic proteins and RNAs. Carcinogenesis.
36:1008–1018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S,
Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of
sorafenib in patients in the Asia-Pacific region with advanced
hepatocellular carcinoma: A phase III randomised, double-blind,
placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lou G, Song X, Yang F, Wu S, Wang J, Chen
Z and Liu Y: Exosomes derived from miR-122-modified adipose
tissue-derived MSCs increase chemosensitivity of hepatocellular
carcinoma. J Hematol Oncol. 8:1222015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
You H, Ding W, Dang H, Jiang Y and
Rountree CB: c-Met represents a potential therapeutic target for
personalized treatment in hepatocellular carcinoma. Hepatology.
54:879–889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Qu Z, Wu J, Wu J, Luo D, Jiang C and Ding
Y: Exosomes derived from HCC cells induce sorafenib resistance in
hepatocellular carcinoma both in vivo and in vitro. J Exp Clin
Cancer Res. 35:1592016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Peleteiro B, Severo M, La Vecchia C and
Lunet N: Model-based patterns in stomach cancer mortality
worldwide. Eur J Cancer Prev. 23:524–531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang N, Wang L, Yang Y, Gong L, Xiao B and
Liu X: A serum exosomal microRNA panel as a potential biomarker
test for gastric cancer. Biochem Biophys Res Commun. 493:1322–1328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya
T, Yashiro M, Hirakawa K, Kosaka T, Makino H, Akiyama H, Kunisaki C
and Endo I: Exosomal miRNAs from peritoneum lavage fluid as
potential prognostic biomarkers of peritoneal metastasis in gastric
cancer. PLoS One. 10:e01304722015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Huang Z, Zhu D, Wu L, He M, Zhou X, Zhang
L, Zhang H, Wang W, Zhu J, Cheng W, et al: Six serum-based miRNAs
as potential diagnostic biomarkers for gastric cancer. Cancer
Epidemiol Biomarkers Prev. 26:188–196. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L,
Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
Novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang H, Deng T, Liu R, Bai M, Zhou L,
Wang X, Li S, Wang X, Yang H, Li J, et al: Exosome-delivered EGFR
regulates liver microenvironment to promote gastric cancer liver
metastasis. Nat Commun. 8:150162017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li C, Liu DR, Li GG, Wang HH, Li XW, Zhang
W, Wu YL and Chen L: CD97 promotes gastric cancer cell
proliferation and invasion through exosome-mediated MAPK signaling
pathway. World J Gastroenterol. 21:6215–6228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Liu D, Li C, Trojanowicz B, Li X, Shi D,
Zhan C, Wang Z and Chen L: CD97 promotion of gastric carcinoma
lymphatic metastasis is exosome dependent. Gastric Cancer.
19:754–766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Zhong H, Yang Y, Ma S, Xiu F, Cai Z, Zhao
H and Du L: Induction of a tumour-specific CTL response by exosomes
isolated from heat-treated malignant ascites of gastric cancer
patients. Int J Hyperthermia. 27:604–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Broere F, van der Zee R and van Eden W:
Heat shock proteins are no DAMPs, rather ‘DAMPERs’. Nat Rev
Immunol. 11:5652011. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
van Eden W, Spiering R, Broere F and van
der Zee R: A case of mistaken identity: HSPs are no DAMPs but
DAMPERs. Cell Stress Chaperones. 17:281–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wang X, Zhang H, Bai M, Ning T, Ge S, Deng
T, Liu R, Zhang L, Ying G and Ba Y: Exosomes serve as nanoparticles
to deliver anti-miR-214 to reverse chemoresistance to cisplatin in
gastric cancer. Mol Ther. 26:774–783. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan
Y, Wang M, Zhu W, Qian H and Xu W: Exosomes derived from human
mesenchymal stem cells confer drug resistance in gastric cancer.
Cell Cycle. 14:2473–2483. 2015. View Article : Google Scholar : PubMed/NCBI
|
